arrow
N

Naoya Yamazaki

National Cancer Center Hospital
H指数:47
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pathologic deep margin distance and prognosis in invasive acral melanoma of the sole

足底侵袭性肢端黑色素瘤的病理学深部切缘距离与预后

2026-11-020
OAAI
Prognostic outcomes of immediate complete lymph node dissection versus observation in patients with acral melanoma of the sole with sentinel node metastasis: a retrospective, multicenter study

跖部肢端黑色素瘤患者中,对于哨兵淋巴结转移患者,即刻完全淋巴结清扫术与观察治疗的预后结局比较:一项回顾性、多中心研究

2025-12-050
PRE
Prognosis of a deep excision margin within or beyond subcutaneous fat for invasive acral melanoma of the sole: A multi-institutional retrospective study

足底侵袭性肢端黑色素瘤的皮下脂肪内或外深部切除边缘的预后:一项多中心回顾性研究

Surgery
IF2.7
2025-07-220
OA
A Case of Microinvasive Malignant Hidroacanthoma Simplex/Porocarcinoma With Folliculo-Sebaceous Differentiation Only at Lymph Nodes Metastases With Absence of YAP1, PAK1/2/3 Fusions

一例微浸润性恶性单纯汗孔棘皮瘤/小汗腺汗孔癌病例,仅在淋巴结转移灶中出现毛囊-皮脂腺分化,且缺乏YAP1、PAK1/2/3融合。

2025-06-300
PRE
Comparing 2 cm vs. 1 cm surgical margins in acral melanoma of the sole with Breslow thickness greater than 2 mm: A multicenter retrospective study of 336 Japanese patients

比较足底肢端黑色素瘤(Breslow厚度大于2 mm)中2 cm与1 cm手术切缘的比较:一项纳入336例日本患者的多中心回顾性研究

2025-06-180
OA
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine

Scrum-monstar癌症组学生态系统: 努力实现精准医学的飞跃

2024-07-161
OAAI
COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma

哥伦布7年更新: 在BRAF V600E/K突变型黑色素瘤患者中,恩科非尼加比尼美替尼与维罗非尼或恩科非尼的随机,开放标签,III期试验

2024-06-016
OAAI
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after de fi nitive surgery: a multicenter, retrospective cohort study (vol 65, 102290, 2023)

Dabrafenib联合曲美替尼与anti-PD-1单药治疗BRAF V600-mutant III期黑色素瘤术后的辅助治疗: 一项多中心,回顾性队列研究 (第65卷,102290,2023)

2024-05-010
OAAI
Analysis of biomarker and outcomes data: 7-year update from COLUMBUS
2024-03-220
PRE